David C. Budd
About
David C. Budd is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience.
According to data from OpenAlex, David C. Budd has authored 51 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in David C. Budd's work include Pulmonary Hypertension Research and Treatments (12 papers), Receptor Mechanisms and Signaling (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). David C. Budd is often cited by papers focused on Pulmonary Hypertension Research and Treatments (12 papers), Receptor Mechanisms and Signaling (9 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). David C. Budd collaborates with scholars based in United Kingdom, United States and Switzerland. David C. Budd's co-authors include Andrew B. Tobin, Alan Holmes, Christoph Walker, Nicholas W. Morrell, David G. Nicholls, Lucy Barker, Carmen Treacy, Joanna Pepke‐Żaba, Elaine Soon and Paul Nicklin and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.
In The Last Decade
David C. Budd
49 papers receiving 2.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| David C. Budd United Kingdom | 26 | 1.1k | 1.1k | 385 | 340 | 198 | 51 | 2.3k | ||
| Israel Fernández‐Cadenas Spain | 30 | 1.1k 1.1× | 349 0.3× | 167 0.4× | 365 1.1× | 151 0.8× | 108 | 2.9k | ||
| Thomas C. Markello United States | 28 | 943 0.9× | 350 0.3× | 241 0.6× | 91 0.3× | 181 0.9× | 68 | 2.5k | ||
| Sylvain Loric France | 29 | 1.1k 1.0× | 558 0.5× | 313 0.8× | 89 0.3× | 193 1.0× | 75 | 2.4k | ||
| Leslie A. Lange United States | 31 | 1.2k 1.1× | 274 0.3× | 246 0.6× | 259 0.8× | 290 1.5× | 87 | 3.0k | ||
| Catherine Rücker‐Martin France | 33 | 1.6k 1.5× | 650 0.6× | 189 0.5× | 1.7k 4.9× | 358 1.8× | 75 | 3.4k | ||
| Laurent Gouya France | 35 | 2.9k 2.7× | 906 0.9× | 147 0.4× | 233 0.7× | 113 0.6× | 116 | 4.1k | ||
| Jacob Schneiderman Israel | 28 | 614 0.6× | 645 0.6× | 618 1.6× | 407 1.2× | 672 3.4× | 100 | 3.0k | ||
| Catherine Léon France | 37 | 987 0.9× | 456 0.4× | 303 0.8× | 1.2k 3.5× | 390 2.0× | 77 | 4.1k | ||
| Lorenz Sellin Germany | 28 | 1.5k 1.4× | 320 0.3× | 104 0.3× | 198 0.6× | 273 1.4× | 59 | 2.8k | ||
| M. Elizabeth Hartnett United States | 43 | 1.7k 1.6× | 1.4k 1.4× | 91 0.2× | 158 0.5× | 197 1.0× | 197 | 6.4k |
Countries citing papers authored by David C. Budd
Since
Specialization
Citations
This map shows the geographic impact of David C. Budd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Budd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Budd more than expected).
Fields of papers citing papers by David C. Budd
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by David C. Budd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Budd. The network helps show where David C. Budd may publish in the future.
Co-authorship network of co-authors of David C. Budd
This figure shows the co-authorship network connecting the top 25 collaborators of David C. Budd. A scholar is included among the top collaborators of David C. Budd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Budd. David C. Budd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ninou, Ioanna, Eleanna Kaffe, David C. Budd, et al.. (2018). Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. 52. 32–40.
2.
Trautmann, Matthias, Javier Sabater, James W. Shaw, et al.. (2014). Relevance of clinical trials to inform HTA: Disparity between hta evidence requirements and published rcts in type 2 diabtetes mellitus. Value in Health. 17(3). A263–A263.
3.
Tang, Xiaoyan, Ruoqi Peng, Jonathan E. Phillips, et al.. (2013). Assessment of Brd4 Inhibition in Idiopathic Pulmonary Fibrosis Lung Fibroblasts and in Vivo Models of Lung Fibrosis. American Journal Of Pathology. 183(2). 470–479.
4.
Moll, Solange, Lyubov Chaykovska, Matthias Meier, et al.. (2013). Targeting the epithelial cells in fibrosis: a new concept for an old disease. Drug Discovery Today. 18(11-12). 582–591.
5.
Tang, Xiaoyan, Ruoqi Peng, Carla M. T. Bauer, et al.. (2012). BET Bromodomain Proteins Mediate Downstream Signaling Events following Growth Factor Stimulation in Human Lung Fibroblasts and Are Involved in Bleomycin-Induced Pulmonary Fibrosis. Molecular Pharmacology. 83(1). 283–293.
6.
Prunotto, Marco, David C. Budd, Giulio Gabbiani, et al.. (2012). Epithelial–mesenchymal crosstalk alteration in kidney fibrosis. The Journal of Pathology. 228(2). 131–147.
7.
Budd, David C. & Alan Holmes. (2012). Targeting TGFβ superfamily ligand accessory proteins as novel therapeutics for chronic lung disorders. Pharmacology & Therapeutics. 135(3). 279–291.
8.
Prunotto, Marco, David C. Budd, Matthias Meier, et al.. (2012). From acute injury to chronic disease: pathophysiological hypothesis of an epithelial/mesenchymal crosstalk alteration in CKD. Nephrology Dialysis Transplantation. 27(suppl 3). iii43–iii50.
9.
Soon, Elaine, Alan Holmes, Carmen Treacy, et al.. (2010). Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension. Circulation. 122(9). 920–927.
10.
Itani, Kamal M.F., et al.. (2009). Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections. PharmacoEconomics. 27(5). 421–430.
11.
Thomas, Matthew, Alan Holmes, Nicholas Duggan, et al.. (2008). Activin-Like Kinase 5 (ALK5) Mediates Abnormal Proliferation of Vascular Smooth Muscle Cells from Patients with Familial Pulmonary Arterial Hypertension and Is Involved in the Progression of Experimental Pulmonary Arterial Hypertension Induced by Monocrotaline. American Journal Of Pathology. 174(2). 380–389.
12.
Dowling, Mark R., Jonathon M. Willets, David C. Budd, et al.. (2006). A Single Point Mutation (N514Y) in the Human M3 Muscarinic Acetylcholine Receptor Reveals Differences in the Properties of Antagonists: Evidence for Differential Inverse Agonism. Journal of Pharmacology and Experimental Therapeutics. 317(3). 1134–1142.
13.
Budd, David C., et al.. (2003). The C-terminal Tail of the M3-muscarinic Receptor Possesses Anti-apoptotic Properties. Journal of Biological Chemistry. 278(21). 19565–19573.
14.
Budd, David C., et al.. (2000). The effects of hair loss in European men: a survey in four countries.. PubMed. 10(2). 122–7.
15.
Budd, David C., John E. McDonald, & Andrew B. Tobin. (2000). Phosphorylation and Regulation of a Gq/11-coupled Receptor by Casein Kinase 1α. Journal of Biological Chemistry. 275(26). 19667–19675.
16.
Budd, David C. & David G. Nicholls. (1998). Arachidonic acid potentiates the duration of the metabotropic, protein kinase C-mediated, suppression of the inhibitory adenosine A1 receptor pathway in glutamatergic nerve terminals from rat cerebral cortex. Neuroscience Letters. 244(3). 133–136.
17.
Budd, David C., et al.. (1996). Inhibition by lifarizine of intracellular Ca2+rises and glutamate exocytosis in depolarized rat cerebrocortical synaptosomes and cultured neurones. British Journal of Pharmacology. 118(1). 162–166.
18.
Budd, David C. & David G. Nicholls. (1995). Protein Kinase C‐Mediated Suppression of the Presynaptic Adenosine A1 Receptor by a Facilitatory Metabotropic Glutamate Receptor. Journal of Neurochemistry. 65(2). 615–621.
19.
Budd, David C., et al.. (1995). Co-existence and interaction between facilitatory and inhibitory metabotropic glutamate receptors and the inhibitory adenosine A1 receptor in cerebrocortical nerve terminals. Neuropharmacology. 34(8). 919–927.
20.
Ko, Kenton, et al.. (1995). Isolation and Characterization of a cDNA Clone Encoding a Member of the Com44/Cim44 Envelope Components of the Chloroplast Protein Import Apparatus. Journal of Biological Chemistry. 270(48). 28601–28608.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Israel Fernández‐Cadenas Breakdown of academic impact, for papers by Thomas C. Markello Breakdown of academic impact, for papers by Sylvain Loric Breakdown of academic impact, for papers by Leslie A. Lange Breakdown of academic impact, for papers by Catherine Rücker‐Martin Breakdown of academic impact, for papers by Laurent Gouya Breakdown of academic impact, for papers by Jacob Schneiderman Breakdown of academic impact, for papers by Catherine Léon Breakdown of academic impact, for papers by Lorenz Sellin Breakdown of academic impact, for papers by M. Elizabeth Hartnett